The Effects of Parent-Child Activity Program on PA of Children With Cancer

NCT06476951 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2024-06-27

No results posted yet for this study

Summary

The goal of this clinical trial is to test the effect of Parent-Child activity program on physical activity of children with cancer. The main question it aims to answer is:

* Whether the Parent-Child activity program has effectiveness for children with cancer on their physical Activity, Physical Activity Self-Efficacy, Physical Activity Enjoyment, Family Support, and for parents on Physical Activity based on the Youth Physical Activity Promotion Model.

Participants will:

* Receive a handbook on information related to physical activity and Parent-Child physical activity when the child is undergoing treatment.
* Participate in Parent-Child activities, such as throw ball catch game, which are organized by the professionals.
* Parents or/and children receive subscriptions on physical activity through WeChat, including the benefits of physical activities and Parent-Child activities, common physical activities and Parent-Child activities, and follow-up video.

Researchers will compare control group to see if there are differences between usual care on physical activity and Parent-Child activity program

Conditions

  • Childhood Cancer
  • Physical Activity
  • Intervention Program
  • Parent-Child Relations

Interventions

BEHAVIORAL

Parent-Child Physical Activity Program

The program includes online education, parent-child games, parent-child dancing, and other parent-child physical activity activities.

Sponsors & Collaborators

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    collaborator OTHER
  • National Natural Science Foundation of China

    collaborator OTHER_GOV
  • Ke Liu

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06476951 on ClinicalTrials.gov